Bruno V.
- Country
- Italy
- Department
- Department of oncology
Research Overview
- Phase III Trial of BI 764532 Plus Carboplatin and Etoposide Versus Carboplatin and Etoposide in Previously Untreated DLL3-Positive Advanced Extrapulmonary Neuroendocrine Carcinoma
- Phase 1/2 Study of EIK1005 Monotherapy and EIK1005 Plus Pembrolizumab in Patients With Advanced Solid Tumors
- (Peak) A Phase 3 Randomized, Open-label, Multicenter Clinical Study of CGT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
Data & Insights
Has run more than one trial at 88 of 186 partner sites.
Specializations
Soft Tissue Sarcomas
Specialized focus on treating dedifferentiated liposarcoma and leiomyosarcoma, particularly in advanced and metastatic cases. Active involvement in evaluating novel therapeutic approaches for retroperitoneal sarcomas.
- Advanced Liposarcoma Management
- Metastatic Leiomyosarcoma Treatment
- Retroperitoneal Sarcoma Therapy
Gastrointestinal Oncology
Expert in treating gastrointestinal stromal tumors (GIST), with particular emphasis on advanced cases and specific genetic mutations. Experience in evaluating targeted therapies for GIST patients previously treated with conventional treatments.
- Advanced GIST Treatment
- KIT Mutation-Specific Therapy
- Second-line Treatment Strategies
Bone and Joint Tumors
Specialized in treating rare bone malignancies including chondrosarcoma and mesenchymal tumors. Focus on managing advanced cases and exploring innovative treatment approaches for bone sarcomas.
- Conventional Chondrosarcoma
- Mesenchymal Chondrosarcoma
- Tenosynovial Giant Cell Tumors
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.